StabiLux Biosciences, Inc

StabiLux Biosciences is a Michigan Tech spinout developing NovoLux High-Brightness Dyes — proprietary fluorophores based on boron nitride nanoparticles that are 2x to 1,000x brighter than any commercial dye. The platform elevates biomedical research by dramatically increasing detection sensitivity in multi-color flow cytometry and supporting applications in early cancer detection, drug discovery, mRNA vaccines, and immunology. StabiLux's technology uses existing dyes and supports new and existing biomolecules including antibodies, RNA sequences, and proteins, enabling detection of previously undetectable biomarkers.